F3 Logic, LLC Eli Lilly & CO Transaction History

F3 Logic, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $345,892 - $376,242	-3,239 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$110.79 - $129.32 $110,457 - $128,932	-997 Reduced 23.54%	3,239 $359,000
Q1 2019 May 06, 2019	BUY	$111.31 - $131.02 $136,354 - $160,499	1,225 Added 40.68%	4,236 $551,000
Q4 2018 Feb 08, 2019	BUY	$105.9 - $118.64 $318,864 - $357,225	3,011 New	3,011 $349,000

4,016

739M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of F3 Logic, LLC, based on Form 13F filings with the SEC.

Stay updated on F3 Logic, LLC with notifications on news.